Postmastectomy Radiation Therapy in Women with T1-T2 Tumors and 1 to 3 Positive Lymph Nodes: Analysis of the Breast International Group 02-98 Trial

Overview

Journal Transl Cancer Res

Specialty Oncology

Date 2022 Feb 4

PMID 35117069

Authors

Fabiana Gregucci

Maria Carmen De Santis

Laura Lozza

Alba Fiorentino

Affiliations

Soon will be listed here.

Citing Articles

Guidelines for breast cancer management in Bosnia and Herzegovina.

Hadzikadic-Gusic L, Ceric T, Marijanovic I, Iljazovic E, Kopric D, Zorlak A Biomol Biomed. 2022; 23(1):2-14.

PMID: 35880400 PMC: 9901905. DOI: 10.17305/bjbms.2022.7504.

References

Zeidan Y, Habib J, Ameye L, Paesmans M, de Azambuja E, Gelber R . Postmastectomy Radiation Therapy in Women with T1-T2 Tumors and 1 to 3 Positive Lymph Nodes: Analysis of the Breast International Group 02-98 Trial. Int J Radiat Oncol Biol Phys. 2018; 101(2):316-324. DOI: 10.1016/j.ijrobp.2018.01.105. View

Recht A, Comen E, Fine R, Fleming G, Hardenbergh P, Ho A . Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update. J Clin Oncol. 2016; 34(36):4431-4442. DOI: 10.1200/JCO.2016.69.1188. View

Kneubil M, Brollo J, Botteri E, Curigliano G, Rotmensz N, Goldhirsch A . Breast cancer subtype approximations and loco-regional recurrence after immediate breast reconstruction. Eur J Surg Oncol. 2013; 39(3):260-5. DOI: 10.1016/j.ejso.2012.12.004. View

Kunkler I, Canney P, van Tienhoven G, Russell N . Elucidating the role of chest wall irradiation in 'intermediate-risk' breast cancer: the MRC/EORTC SUPREMO trial. Clin Oncol (R Coll Radiol). 2008; 20(1):31-4. DOI: 10.1016/j.clon.2007.10.004. View

Tseng Y, Uno H, Hughes M, Niland J, Wong Y, Theriault R . Biological Subtype Predicts Risk of Locoregional Recurrence After Mastectomy and Impact of Postmastectomy Radiation in a Large National Database. Int J Radiat Oncol Biol Phys. 2015; 93(3):622-30. DOI: 10.1016/j.ijrobp.2015.07.006. View

Taghian A, Jeong J, Mamounas E, Anderson S, Bryant J, Deutsch M . Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project.... J Clin Oncol. 2004; 22(21):4247-54. DOI: 10.1200/JCO.2004.01.042. View

Frasier L, Holden S, Holden T, Schumacher J, Leverson G, Anderson B . Temporal Trends in Postmastectomy Radiation Therapy and Breast Reconstruction Associated With Changes in National Comprehensive Cancer Network Guidelines. JAMA Oncol. 2015; 2(1):95-101. PMC: 4713236. DOI: 10.1001/jamaoncol.2015.3717. View

Curigliano G, Burstein H, Winer E, Gnant M, Dubsky P, Loibl S . De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017. Ann Oncol. 2017; 28(8):1700-1712. PMC: 6246241. DOI: 10.1093/annonc/mdx308. View

Sartor C, Peterson B, Woolf S, Fitzgerald T, Laurie F, Turrisi A . Effect of addition of adjuvant paclitaxel on radiotherapy delivery and locoregional control of node-positive breast cancer: cancer and leukemia group B 9344. J Clin Oncol. 2004; 23(1):30-40. DOI: 10.1200/JCO.2005.12.044. View

10.

Sonnenblick A, Francis P, Azim Jr H, de Azambuja E, Nordenskjold B, Gutierez J . Final 10-year results of the Breast International Group 2-98 phase III trial and the role of Ki67 in predicting benefit of adjuvant docetaxel in patients with oestrogen receptor positive breast cancer. Eur J Cancer. 2015; 51(12):1481-9. DOI: 10.1016/j.ejca.2015.03.018. View

11.

McGale P, Taylor C, Correa C, Cutter D, Duane F, Ewertz M . Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet. 2014; 383(9935):2127-35. PMC: 5015598. DOI: 10.1016/S0140-6736(14)60488-8. View